Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Pro...
Uložené v:
| Vydané v: | Oncogenesis (New York, NY) Ročník 11; číslo 1; s. 54 - 12 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
Nature Publishing Group UK
15.09.2022
Nature Publishing Group |
| Predmet: | |
| ISSN: | 2157-9024, 2157-9024 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications. |
|---|---|
| AbstractList | Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications. Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications.Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications. Abstract Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications. |
| ArticleNumber | 54 |
| Author | Wang, Xia Lu, Jingyi Ng, Irene Oi-Lin Tian, Lu |
| Author_xml | – sequence: 1 givenname: Xia surname: Wang fullname: Wang, Xia organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong – sequence: 2 givenname: Lu surname: Tian fullname: Tian, Lu organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong – sequence: 3 givenname: Jingyi surname: Lu fullname: Lu, Jingyi organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong – sequence: 4 givenname: Irene Oi-Lin orcidid: 0000-0001-7532-2029 surname: Ng fullname: Ng, Irene Oi-Lin email: iolng@hku.hk organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong |
| BookMark | eNp9UstqHDEQFMEmdhz_QE4LueQyiZ4r6RIIfiQGgyHYZ6GRWrvazEobacYkf--ZHedhH6xLS91VpaKpN-gg5QQIvSP4I8FMfaqcMKUbTGmDMWekEa_QMSVCNhpTfvDf_Qid1rrB4xFLshTiNTpiS4K1wOQYfb_4lWveQl3Y5BfOJgdl0SzOo12lXPvo9v1dyX-ebcxbW35AmRn9GordwTCN7mEdXQdv0WGwXYXTx3qC7i4vbs--Ndc3X6_Ovlw3TijWN0ISp1oXJLE-WMwDaQPx2jsFBHTgWFFrqccYFFvKoB1rg5dYgcfOt4qyE3Q16_psN2ZX4ujrt8k2mn0jl5WxpZ8cGR-YJpgwIC3w4LymwkrLrOKceM_9qPV51toN7Ra8g9QX2z0RfTpJcW1W-d5oLqWiehT48ChQ8s8Bam-2sTroOpsgD9VQSQRnSmg8Qt8_g27yUNK4qgnFpVJaiBFFZ5QrudYC4a8Zgs2UADMnwIwJMPsEmImknpFc7G0f82Q6di9T2Uyt4z9pBeWfqxdYDxEvxy0 |
| CitedBy_id | crossref_primary_10_1038_s44328_025_00047_w crossref_primary_10_3389_fimmu_2024_1368898 crossref_primary_10_3390_cells12030356 crossref_primary_10_1021_acsabm_4c01920 crossref_primary_10_3390_life14030408 crossref_primary_10_1016_j_prp_2025_155873 crossref_primary_10_1002_smtd_202400426 crossref_primary_10_3390_ncrna8060075 crossref_primary_10_3390_cancers15092479 crossref_primary_10_1016_j_abb_2024_110277 crossref_primary_10_1016_j_talanta_2025_128411 crossref_primary_10_1007_s11033_025_10535_x crossref_primary_10_1016_j_bbcan_2025_189308 crossref_primary_10_1007_s00266_025_05073_7 crossref_primary_10_1016_j_ncrna_2024_11_005 crossref_primary_10_1007_s12031_025_02315_w crossref_primary_10_1016_j_cca_2023_117705 crossref_primary_10_1016_j_omton_2024_200887 crossref_primary_10_1016_j_prp_2024_155766 crossref_primary_10_1080_10408347_2025_2530177 crossref_primary_10_1002_ctd2_208 crossref_primary_10_1016_j_ntm_2025_100096 crossref_primary_10_3390_pharmaceutics16050654 crossref_primary_10_34172_bi_31211 crossref_primary_10_1002_mabi_202300159 crossref_primary_10_1007_s12013_025_01730_5 crossref_primary_10_1016_j_talanta_2024_126619 crossref_primary_10_1093_bib_bbae075 crossref_primary_10_1097_TP_0000000000004693 crossref_primary_10_3389_fonc_2024_1459178 crossref_primary_10_1016_j_pbiomolbio_2024_08_002 crossref_primary_10_1128_msphere_00764_24 crossref_primary_10_1016_j_foodchem_2025_143425 crossref_primary_10_1007_s40291_024_00715_z crossref_primary_10_1186_s12885_025_14375_7 crossref_primary_10_2147_IJN_S464249 crossref_primary_10_1016_j_lfs_2024_122985 crossref_primary_10_29333_ejgm_13456 crossref_primary_10_1016_j_prp_2024_155214 crossref_primary_10_1016_j_aca_2023_341910 crossref_primary_10_3390_ijms25063562 crossref_primary_10_1016_j_talanta_2025_128505 crossref_primary_10_3390_biology13090716 crossref_primary_10_1021_acsnano_5c06940 crossref_primary_10_1016_j_lfs_2024_122747 crossref_primary_10_3724_abbs_2025123 crossref_primary_10_1016_j_pscia_2025_100075 crossref_primary_10_1016_j_bcp_2025_117019 crossref_primary_10_1158_1940_6207_CAPR_22_0469 crossref_primary_10_1186_s40364_024_00685_8 crossref_primary_10_1016_j_bioorg_2024_107589 crossref_primary_10_1016_j_adcanc_2023_100103 crossref_primary_10_3390_molecules28104227 crossref_primary_10_1016_j_drup_2023_100937 crossref_primary_10_3390_membranes12121244 crossref_primary_10_1089_dcbr_2025_0019 crossref_primary_10_1016_j_lfs_2024_123280 crossref_primary_10_1016_j_tice_2025_102749 crossref_primary_10_33549_physiolres_935153 crossref_primary_10_1038_s41598_024_67934_6 crossref_primary_10_1186_s12014_024_09489_2 crossref_primary_10_1002_smll_202502763 crossref_primary_10_1063_5_0220840 crossref_primary_10_1002_ctd2_70063 crossref_primary_10_3390_biomedicines12081696 crossref_primary_10_1016_j_bbcan_2025_189315 crossref_primary_10_1186_s12935_024_03606_9 crossref_primary_10_3390_diseases12090221 crossref_primary_10_1016_j_vesic_2025_100089 crossref_primary_10_3390_pharmaceutics15082042 crossref_primary_10_1002_adfm_202418138 crossref_primary_10_3390_ijms241814356 crossref_primary_10_3389_fcell_2024_1372847 crossref_primary_10_3390_cancers15082256 crossref_primary_10_1021_acsabm_5c00318 crossref_primary_10_3389_fonc_2024_1437542 crossref_primary_10_1016_j_abb_2023_109718 crossref_primary_10_1021_acsabm_5c00955 crossref_primary_10_1515_biol_2022_0899 crossref_primary_10_7717_peerj_15798 crossref_primary_10_1021_acsabm_5c00288 crossref_primary_10_3389_fonc_2023_1131435 crossref_primary_10_3390_biomedicines12010123 crossref_primary_10_1136_jitc_2024_010928 crossref_primary_10_1016_j_biopha_2024_117735 crossref_primary_10_3390_ijms25010371 crossref_primary_10_1177_00368504251362350 crossref_primary_10_1016_j_prp_2025_155950 crossref_primary_10_1186_s12935_024_03522_y crossref_primary_10_1039_D5NH00557D crossref_primary_10_1016_j_nexres_2025_100434 crossref_primary_10_4252_wjsc_v17_i4_102917 crossref_primary_10_1038_s41390_025_03856_x crossref_primary_10_1016_j_mtbio_2024_101433 crossref_primary_10_1021_jacs_5c11289 crossref_primary_10_23736_S1825_859X_23_00211_6 crossref_primary_10_1038_s41598_024_79425_9 crossref_primary_10_1016_j_gendis_2025_101682 crossref_primary_10_1016_j_bbcan_2023_188914 crossref_primary_10_3389_fphar_2025_1550208 crossref_primary_10_3390_cancers17121929 crossref_primary_10_1002_mco2_70388 crossref_primary_10_3390_cancers16152765 crossref_primary_10_1186_s12935_024_03379_1 crossref_primary_10_1039_D5TB00993F crossref_primary_10_1165_rcmb_2022_0380ED crossref_primary_10_3390_jpm14050482 crossref_primary_10_3390_diagnostics15050628 crossref_primary_10_1158_1541_7786_MCR_24_0052 crossref_primary_10_1007_s00216_023_04546_5 crossref_primary_10_3390_ijms26020526 crossref_primary_10_1016_j_jconrel_2023_11_005 crossref_primary_10_1016_j_talanta_2023_124548 crossref_primary_10_1002_adma_202303736 crossref_primary_10_1007_s10876_024_02676_z crossref_primary_10_1016_j_bmi_2025_100007 crossref_primary_10_1080_14796694_2025_2539627 crossref_primary_10_1186_s12967_025_06883_8 crossref_primary_10_1016_j_heliyon_2024_e34460 crossref_primary_10_3390_ijms26073137 crossref_primary_10_1177_11795549231215966 crossref_primary_10_1186_s12943_024_01932_0 crossref_primary_10_3389_fimmu_2024_1473030 crossref_primary_10_3389_fonc_2023_1203359 crossref_primary_10_3390_ph18071005 crossref_primary_10_1002_jev2_70088 crossref_primary_10_1016_j_cca_2025_120532 crossref_primary_10_1016_j_canlet_2024_217084 crossref_primary_10_1016_j_ejpb_2024_114460 crossref_primary_10_1186_s12935_025_03806_x crossref_primary_10_1186_s12935_024_03464_5 crossref_primary_10_3390_pharmaceutics15020663 crossref_primary_10_1371_journal_pone_0282814 crossref_primary_10_1016_j_drudis_2024_104061 crossref_primary_10_3389_fnins_2024_1426700 crossref_primary_10_1016_j_cej_2023_142842 crossref_primary_10_1186_s13054_025_05477_6 crossref_primary_10_1002_smtd_202500919 crossref_primary_10_1515_oncologie_2024_0571 crossref_primary_10_1016_j_critrevonc_2024_104341 crossref_primary_10_1016_j_cca_2024_120105 crossref_primary_10_1002_aidi_202500040 crossref_primary_10_3390_ijms252313045 crossref_primary_10_1002_cam4_70941 crossref_primary_10_1186_s43556_025_00280_9 crossref_primary_10_1002_iid3_1325 crossref_primary_10_3390_cancers16142552 crossref_primary_10_3390_ijms24020965 |
| Cites_doi | 10.7150/thno.46568 10.1016/j.canlet.2015.07.014 10.7150/jca.48531 10.1111/j.1365-2559.2007.02635.x 10.1186/1479-5876-3-9 10.1016/j.cell.2020.07.009 10.1016/j.cytogfr.2021.08.002 10.7150/thno.17092 10.1186/s12951-018-0437-z 10.1038/cr.2014.44 10.1074/jbc.C113.532267 10.1371/journal.pone.0004942 10.1038/ncb3169 10.1186/s12943-018-0897-7 10.1016/j.bcmd.2005.05.003 10.1056/NEJMoa1606774 10.1007/s10555-019-09783-8 10.3402/jev.v4.27031 10.1021/acsnano.5b07584 10.1186/s13046-019-1313-x 10.1016/S0092-8674(00)81688-8 10.1038/nature14581 10.1038/srep42339 10.1111/j.1600-0854.2009.00963.x 10.1016/j.canlet.2017.03.004 10.1080/20013078.2019.1697028 10.1007/s00383-016-3960-8 10.1200/JCO.2012.45.2011 10.1038/s41467-020-18311-0 10.1016/j.canlet.2020.08.030 10.1016/j.bbamem.2011.07.026 10.1056/NEJMra1704286 10.1186/s12951-022-01472-z 10.1016/j.jhep.2020.04.044 10.1038/nbt.2886 10.1038/s41467-017-01942-1 10.2147/OTT.S140062 10.1111/j.1582-4934.2005.tb00494.x 10.1158/0008-5472.CAN-16-2634 10.1002/advs.202002157 10.1016/S0959-8049(02)00166-1 10.1186/s12943-018-0831-z 10.1111/jcmm.13056 10.1007/s00018-017-2595-9 10.1080/10717544.2020.1748758 10.1186/s12964-021-00730-1 10.1016/j.ejps.2016.09.010 10.1038/s41598-019-41800-2 10.1186/s13046-019-1095-1 10.1016/j.canlet.2021.01.006 10.1016/j.bbrc.2013.07.044 10.3390/vaccines8040706 10.1038/s41388-020-01450-5 10.1172/JCI81137 10.1186/s12951-019-0563-2 10.1111/jcmm.12941 10.1016/j.tranon.2019.07.009 10.18632/aging.103366 10.1038/mt.2008.1 10.1002/stem.3113 10.4049/jimmunol.1400703 10.1165/rcmb.2017-0248OC 10.1016/j.celrep.2019.05.008 10.1186/s12951-021-00986-2 10.1016/j.tcb.2018.06.007 10.1080/20013078.2018.1435138 10.1158/1535-7163.MCT-14-0983 10.1038/nrm.2017.125 10.3892/ijo.2014.2256 10.1080/14756366.2020.1754814 10.7150/jca.31241 10.1038/emm.2014.114 10.2147/IJN.S218988 10.1038/s41417-020-00238-9 10.1158/1541-7786.MCR-19-0588 10.1007/s13277-015-3741-3 10.1007/s40291-017-0278-8 10.3402/jev.v5.31292 10.1186/s12916-018-1163-y 10.1038/bjc.2017.183 10.1038/ncomms3712 10.1021/acs.bioconjchem.8b00732 10.1038/nature15376 10.1016/j.cellimm.2020.104258 10.1182/blood-2008-04-153536 10.1038/s41586-018-0392-8 10.1016/j.actbio.2019.05.054 10.1016/j.biomaterials.2013.07.102 10.1002/ijc.31931 10.1158/1078-0432.CCR-05-0810 10.1186/s12943-017-0706-8 10.1002/mc.22935 10.1073/pnas.1017667108 10.1074/mcp.M112.021303 10.1371/journal.pone.0141448 10.18632/oncotarget.6045 10.1523/JNEUROSCI.2569-15.2016 10.1186/s12943-017-0714-8 10.1038/s41467-021-25990-w 10.1007/s00018-019-03052-1 10.1158/2159-8290.CD-15-1483 10.1002/jev2.12031 10.18632/oncotarget.14795 10.26508/lsa.201800093 10.1002/jev2.12134 10.4049/jimmunol.1901104 10.1038/ni854 10.1111/cas.14181 10.1186/1479-5876-10-134 10.1016/j.canlet.2021.05.017 10.1158/2159-8290.CD-20-1311 10.2147/IJN.S200036 10.1074/jbc.M115.671735 10.1002/eji.201343660 10.1080/20013078.2019.1703244 10.1016/j.bios.2020.112452 10.1096/fj.201601138RR 10.1038/emm.2015.68 10.1038/nature13954 10.1038/nm.2753 10.1080/20013078.2020.1809765 10.1016/j.talanta.2021.123089 10.1158/1055-9965.EPI-18-0569 10.1038/nature15756 10.15252/embj.201696003 10.3389/fcell.2022.728616 10.1038/sj.bjc.6605608 10.1038/ncb2502 10.1016/j.jhep.2011.04.026 10.18632/oncotarget.20881 10.1126/science.1153124 10.1093/annonc/mdx542 10.1038/bjc.2018.9 10.1309/AJCPAVFA8J3KHPRS 10.1371/journal.pone.0166027 10.1186/s12943-018-0817-x 10.1096/fj.202002730R 10.4161/onci.20897 10.1038/s41467-020-15569-2 10.1038/ncomms4591 10.3402/jev.v4.26659 10.1371/journal.pone.0215990 10.1038/bjc.2014.621 10.1038/cr.2015.82 10.1038/s41467-018-07947-8 10.1080/2162402X.2019.1593805 10.3390/cancers11030429 10.3402/jev.v2i0.20360 10.3390/cancers11101449 10.1038/s41388-019-0771-0 10.1002/jcb.27165 10.1186/s12943-019-1041-z 10.1186/s12943-022-01509-9 10.1002/jcb.26650 10.7150/thno.21945 10.3390/ijms23042180 10.1021/jacs.9b13960 10.1126/science.aau6977 10.1126/scitranslmed.aaz3426 10.1080/20013078.2020.1791450 10.3390/jcm5030030 10.1073/pnas.1618088114 10.1158/1078-0432.CCR-18-1941 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). |
| Copyright_xml | – notice: The Author(s) 2022 – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). |
| DBID | C6C AAYXX CITATION 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41389-022-00431-5 |
| DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea ProQuest Health & Medical Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Science Database (ProQuest) Biological Science Database (ProQuest) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2157-9024 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_df391013e1be4fcd925a7a3a8441dd4d PMC9477829 10_1038_s41389_022_00431_5 |
| GrantInformation_xml | – fundername: Innovation and Technology Commission (ITF) grantid: N/A funderid: https://doi.org/10.13039/501100003452 – fundername: Hong Kong Research Grants Council – fundername: ; – fundername: ; grantid: N/A |
| GroupedDBID | 0R~ 3V. 53G 5VS 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBLON EBS FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE KQ8 LK8 M0L M2P M48 M7P M~E NAO OK1 PGMZT PIMPY PQQKQ PROAC RNT RNTTT RPM SNYQT UKHRP AASML AAYXX CITATION 7XB 8FK K9. PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c583t-571c8bcf71adfa04f1bf1d9dc8e1e9f4082aa2d00e8367f9c3bfd708ed0cdb823 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 170 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000854766400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2157-9024 |
| IngestDate | Fri Oct 03 12:51:11 EDT 2025 Tue Nov 04 02:07:03 EST 2025 Thu Sep 04 15:51:22 EDT 2025 Sat Nov 29 14:29:38 EST 2025 Tue Nov 18 20:53:23 EST 2025 Sat Nov 29 02:53:39 EST 2025 Fri Feb 21 02:40:42 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c583t-571c8bcf71adfa04f1bf1d9dc8e1e9f4082aa2d00e8367f9c3bfd708ed0cdb823 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-7532-2029 |
| OpenAccessLink | https://doaj.org/article/df391013e1be4fcd925a7a3a8441dd4d |
| PMID | 36109501 |
| PQID | 2714788955 |
| PQPubID | 2041913 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_df391013e1be4fcd925a7a3a8441dd4d pubmedcentral_primary_oai_pubmedcentral_nih_gov_9477829 proquest_miscellaneous_2715438590 proquest_journals_2714788955 crossref_primary_10_1038_s41389_022_00431_5 crossref_citationtrail_10_1038_s41389_022_00431_5 springer_journals_10_1038_s41389_022_00431_5 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-09-15 |
| PublicationDateYYYYMMDD | 2022-09-15 |
| PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: New York |
| PublicationTitle | Oncogenesis (New York, NY) |
| PublicationTitleAbbrev | Oncogenesis |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Dong, Holth, Kleinberg, Ruud, Elstrand, Tropé (CR147) 2009; 132 Yu, Gai, Li, Ding, Zheng, Zhang (CR166) 2019; 110 Vallabhaneni, Hassler, Abraham, Whitt, Mo, Atfi (CR6) 2016; 11 Yu, Zhang, Zhang, Han, Li, Mao (CR67) 2019; 10 CR39 Tian, Gong, Hu, Liu, Zhang, Zhang (CR45) 2020; 9 Li, Wu, Liu, Xu, Qiu, Huang (CR174) 2021; 19 CR36 Schierer, Ostalecki, Zinser, Lamprecht, Plosnita, Stich (CR63) 2018; 1 Li, Liu, Zang, Zhou, Zhang, Sun (CR51) 2020; 492 Segura, Amigorena, Thery (CR59) 2005; 35 Pitt, Charrier, Viaud, Andre, Besse, Chaput (CR158) 2014; 193 Smith, Selby, Johnston, Such (CR35) 2019; 30 Liu, Yuan, Pang, Xue, Yan (CR46) 2022; 239 Hoshino, Costa-Silva, Shen, Rodrigues, Hashimoto, Mark (CR33) 2015; 527 Viaud, Terme, Flament, Taieb, Andre, Novault (CR9) 2009; 4 Tang, Wong (CR87) 2015; 367 Zhang, Lu, Liu, Zhang, Lu (CR151) 2020; 35 Tauro, Greening, Mathias, Mathivanan, Ji, Simpson (CR107) 2013; 12 Reck, Rodriguez-Abreu, Robinson, Hui, Csoszi, Fulop (CR20) 2016; 375 Colombo, Moita, van Niel, Kowal, Vigneron, Benaroch (CR24) 2013; 126 Diaz, Bardelli (CR84) 2014; 32 Im, Shao, Park, Peterson, Castro, Weissleder (CR18) 2014; 32 Kajimoto, Okada, Miya, Zhang, Nakamura (CR26) 2013; 4 Quah, O’Neill (CR157) 2005; 9 Mikamori, Yamada, Eguchi, Hasegawa, Kishimoto, Tomimaru (CR133) 2017; 7 CR49 Li, Li, Zhou, Liu, Liu, Li (CR99) 2017; 16 van Niel, D’Angelo, Raposo (CR1) 2018; 19 CR48 Mao, Zhou, Tey, Ma, Yeung, Ng (CR83) 2020; 10 Buschow, Nolte-‘t Hoen, Niel, Pols, Broeke, Lauwen (CR27) 2009; 10 Stevic, Müller, Weber, Fasching, Karn, Marmé (CR132) 2018; 16 Sharma, Ludwig, Muller, Hong, Kirkwood, Ferrone (CR37) 2018; 7 Marleau, Chen, Joyce, Tullis (CR155) 2012; 10 Jakobsen, Paulsen, Bæk, Varming, Sorensen, Jørgensen (CR97) 2015; 4 Sharma, Huang, Brekken, Schroit (CR148) 2017; 117 Rubenich, Omizzollo, Szczepanski, Reichert, Whiteside, Ludwig (CR69) 2021; 61 Buscail, Chauvet, Quincy, Degrandi, Buscail, Lamrissi (CR102) 2019; 12 Zuo, Qi, Lu, Chen, Sun, Yang (CR7) 2020; 11 Thery, Duban, Segura, Veron, Lantz, Amigorena (CR60) 2002; 3 Zhu, Cao, Liang, Li, Hao, Meng (CR77) 2021; 506 Qazi, Gehrmann, Domange Jordo, Karlsson, Gabrielsson (CR62) 2009; 113 Mhawech-Fauceglia, Zhang, Terracciano, Sauter, Chadhuri, Herrmann (CR109) 2007; 50 Chen, Lin, Chiou, Harn (CR160) 2020; 32 Peng, Zhang, Yang, Zhang, Wei, Jiang (CR172) 2013; 34 CR141 Vallabhapurapu, Blanco, Sulaiman, Vallabhapurapu, Chu, Franco (CR146) 2015; 6 Overmiller, Pierluissi, Wermuth, Sauma, Martinez-Outschoorn, Tuluc (CR79) 2017; 31 Ito, Kudo, Higuchi, Otsuka, Tanaka, Fukunishi (CR76) 2021; 35 Liu, Chen, Liu (CR118) 2016; 32 Thakur, Zhang, Becker, Matei, Huang, Costa-Silva (CR143) 2014; 24 Trajkovic, Hsu, Chiantia, Rajendran, Wenzel, Wieland (CR25) 2008; 319 Chen, Liang, Zeng, Zhao, Guo, Zhong (CR16) 2020; 11 CR50 CR134 Liang, Zhu, Ali, Tian, Xu, Si (CR170) 2020; 18 Langemeyer, Fröhlich, Ungermann (CR31) 2018; 28 Costa-Silva, Aiello, Ocean, Singh, Zhang, Thakur (CR4) 2015; 17 Song, Trajkovic, Tsunemi, Krainc (CR29) 2016; 36 Alix-Panabières, Pantel (CR85) 2016; 6 Zhu, Shen, Yin, Yang, Wei, Chen (CR65) 2019; 38 Hessvik, Llorente (CR30) 2017; 75 Thind, Wilson (CR119) 2016; 5 Zhang, Wang, Wang, Zou, Mei, Peng (CR52) 2021; 28 Meng, He, Hao, Wang, Li, Zhu (CR165) 2020; 27 Bellavia, Raimondo, Calabrese, Forte, Cristaldi, Patinella (CR23) 2017; 7 Cappello, Logozzi, Campanella, Bavisotto, Marcilla, Properzi (CR90) 2017; 96 Oszvald, Szvicsek, Sandor, Kelemen, Soos, Paloczi (CR3) 2020; 38 Riedl, Rinner, Asslaber, Schaider, Walzer, Novak (CR145) 2011; 1808 CR150 Wu, Zhou, Mei, Wu, Mu, Chen (CR129) 2017; 21 Sun, Lee, Zhang, Kao, Teng, Yang (CR17) 2020; 11 Baietti, Zhang, Mortier, Melchior, Degeest, Geeraerts (CR28) 2012; 14 Yang, Feng, Liu, Tong, Wu, Li (CR75) 2020; 39 Antonyak, Li, Boroughs, Johnson, Druso, Bryant (CR74) 2011; 108 Wei, Wang, Wang, Han, Rong, Wang (CR57) 2020; 12 Fu, Zhou, Mi, Jiang (CR156) 2020; 8 Wei, Chen, Wang, Fu, Zhu, Wu (CR167) 2019; 14 Cao, Wang, Yu, Jiang, Li, Zhao (CR43) 2020; 166 Yuwen, Ma, Wang, Gao, Li, Xue (CR131) 2019; 28 Bellavia, Raimondo, Calabrese, Forte, Cristaldi, Patinella (CR169) 2017; 7 Cianciaruso, Beltraminelli, Duval, Nassiri, Hamelin, Mozes (CR164) 2019; 27 Im, Shao, Park, Peterson, Castro, Weissleder (CR108) 2014; 32 Catalano, O’Driscoll (CR152) 2020; 9 Shah, Patel, Freedman (CR88) 2018; 379 Bhan, Soleimani, Mandal (CR137) 2017; 77 Castillo, Bernard, San Lucas, Allenson, Capello, Kim (CR100) 2018; 29 Lea, Sharma, Yang, Zhu, Ward, Schroit (CR149) 2017; 8 Peinado, Aleckovic, Lavotshkin, Matei, Costa-Silva, Moreno-Bueno (CR98) 2012; 18 Tkach, Kowal, Zucchetti, Enserink, Jouve, Lankar (CR61) 2017; 36 Xiao, Dong, Zhen, Xia, Huang, Wang (CR103) 2020; 18 Alix-Panabières, Pantel (CR86) 2021; 11 Tsujiura, Ichikawa, Komatsu, Shiozaki, Takeshita, Kosuga (CR116) 2010; 102 CR71 Zhang, Li, Sun, Yue, Yang, Li (CR2) 2017; 397 Wang, Ding, Yaqoob, de Assuncao, Verma, Hirsova (CR58) 2015; 290 Fenselau, Ostrand-Rosenberg (CR72) 2021; 359 Sancho-Albero, Navascués, Mendoza, Sebastián, Arruebo, Martín-Duque (CR32) 2019; 17 Fornari, Ferracin, Trerè, Milazzo, Marinelli, Galassi (CR123) 2015; 10 Lobb, Becker, Wen, Wong, Wiegmans, Leimgruber (CR38) 2015; 4 CR117 Patel, Khan, Zubair, Srivastava, Khushman, Singh (CR173) 2019; 9 Di, Mi, Sun, Liu, Liu, Li (CR40) 2020; 10 Logozzi, Spugnini, Mizzoni, Di Raimo, Fais (CR93) 2019; 38 Chen, Huang, Zhang, Zhang, Wu, Xu (CR112) 2018; 560 Zhao, Zhang, Zhang, Yang, Zheng, Li (CR140) 2018; 17 Lee, Kim, Tak, Jang, Kweon, Park (CR138) 2019; 144 Tomimaru, Eguchi, Nagano, Wada, Kobayashi, Marubashi (CR115) 2012; 56 Hunter (CR104) 2000; 100 Huang, Hsueh, Shen, Guo, Huang, Zhang (CR78) 2021; 517 Gurung, Perocheau, Touramanidou, Baruteau (CR34) 2021; 19 CR124 CR125 Liu, Hu, Zhou, Chen, Wang, Liao (CR126) 2017; 10 Xie, Zhang, Zhao, Li, Xiang (CR73) 2013; 438 CR120 Sohn, Kim, Kang, Yang, Cho, Cho (CR122) 2015; 47 Lacy, Woeller, Thatcher, Pollock, Small, Sime (CR53) 2019; 60 CR80 Zhang, Zhan, Yao, Lowery, Zhang, Huang (CR56) 2015; 527 Giampieri, Piva, Occhipinti, Bittoni, Righetti, Pagliaretta (CR94) 2019; 14 Olmedillas-López, García-Arranz, García-Olmo (CR47) 2017; 21 Sun, Shi, Yang, Liu, Zhou, Wang (CR12) 2018; 17 Melo, Luecke, Kahlert, Fernandez, Gammon, Kaye (CR11) 2015; 523 Del, Marconcini, Pasquini, Rofi, Vivaldi, Bloise (CR113) 2018; 118 Vakhshiteh, Atyabi, Ostad (CR161) 2019; 14 Haluska, Dy, Adjei (CR154) 2002; 38 Morse, Garst, Osada, Khan, Hobeika, Clay (CR64) 2005; 3 Wang, Xie, Li, Sang, Yan, Li (CR153) 2021; 12 CR14 Yoshioka, Kosaka, Konishi, Ohta, Okamoto, Sonoda (CR44) 2014; 5 Yin, Ma, Huang, Lin, Zhou, Yan (CR66) 2019; 38 CR13 Lawson, Dickman, Towle, Jabalee, Javer, Garnis (CR81) 2019; 58 Jeong, Park, Pathania, Castro, Weissleder, Lee (CR42) 2016; 10 CR96 CR95 Liu, Mendes, Berkman (CR110) 2014; 44 Dai, Wan, Wang, Zhou, Xiu, Chen (CR15) 2005; 11 CR92 CR91 Wei, Wu, Kang, Sun, Heskia, Pachot (CR41) 2020; 9 Li, Chen, Guo, Zhou, Jia, Peng (CR101) 2017; 21 Wang, Hou, Li, Duan, Gao, Song (CR121) 2014; 2014 Hoshino, Kim, Bojmar, Gyan, Cioffi, Hernandez (CR111) 2020; 182 Qu, Wu, Wu, Ji, Qiang, Jiang (CR128) 2017; 8 Caivano, Laurenzana, De Luca, La Rocca, Simeon, Trino (CR89) 2015; 36 Patel, Kurzrock (CR114) 2015; 14 Zhang, Liu, Zhang, Huang, Tang, Chai (CR168) 2022; 20 Yoon, Kim, Choi (CR70) 2015; 47 Guo, Duan, Zhang, Wang, He, Liu (CR8) 2020; 205 Tumeh, Harview, Yearley, Shintaku, Taylor, Robert (CR19) 2014; 515 Gao, Wei, de Assuncao, Liu, Hu, Ibrahim (CR54) 2020; 73 Sun, Yang, Zhou, Wang, Song, Li (CR136) 2018; 17 Yuwen, Sheng, Liu, Wenyu, Shu (CR130) 2017; 21 Hu, Sheng, Kwak, Shi, Yu, Lee (CR135) 2017; 8 Chen, Wang, Zhu, Xu, Liu, Li (CR171) 2022; 10 CR21 Rayamajhi, Nguyen, Marasini, Aryal (CR22) 2019; 94 CR105 Sugimachi, Matsumura, Hirata, Uchi, Ueda, Ueo (CR127) 2015; 112 Xue, Chen, Xiang, Wang, Chen, Pan (CR139) 2017; 16 Dai, Wei, Wu, Zhou, Wei, Huang (CR163) 2008; 16 Mao, Tey, Yeung, Kwong, Fung, Chung (CR82) 2020; 7 Kahlert, Melo, Protopopov, Tang, Seth, Koch (CR144) 2014; 289 Munich, Sobo-Vujanovic, Buchser, Beer-Stolz, Vujanovic (CR10) 2012; 1 Pitt, Andre, Amigorena, Soria, Eggermont, Kroemer (CR159) 2016; 126 Szvicsek, Oszvald, Szabo, Sandor, Kelemen, Soos (CR55) 2019; 76 Lee, Kim, Kim (CR68) 2014; 44 Li, Zheng, Bao, Li, Guo, Zhao (CR142) 2015; 25 Shi, Yang, Monsel, Yan, Dai, Zhao (CR162) 2021; 10 Miyazoe, Miuma, Miyaaki, Kanda, Nakashiki, Sasaki (CR5) 2020; 12 CR106 X Zhu (431_CR65) 2019; 38 F Fornari (431_CR123) 2015; 10 MA Morse (431_CR64) 2005; 3 S Olmedillas-López (431_CR47) 2017; 21 W Li (431_CR99) 2017; 16 J Lea (431_CR149) 2017; 8 H Im (431_CR18) 2014; 32 BK Thakur (431_CR143) 2014; 24 431_CR36 J Guo (431_CR8) 2020; 205 R Wang (431_CR58) 2015; 290 L Zhang (431_CR56) 2015; 527 MA Antonyak (431_CR74) 2011; 108 B Zuo (431_CR7) 2020; 11 431_CR150 H Wang (431_CR121) 2014; 2014 MK Tang (431_CR87) 2015; 367 C Cianciaruso (431_CR164) 2019; 27 YR Lee (431_CR138) 2019; 144 L Chen (431_CR171) 2022; 10 G Wang (431_CR153) 2021; 12 S Jeong (431_CR42) 2016; 10 Y Yoshioka (431_CR44) 2014; 5 X Mao (431_CR82) 2020; 7 F Vakhshiteh (431_CR161) 2019; 14 R Giampieri (431_CR94) 2019; 14 W Liu (431_CR118) 2016; 32 SI Buschow (431_CR27) 2009; 10 HP Dong (431_CR147) 2009; 132 C Kahlert (431_CR144) 2014; 289 J Gao (431_CR54) 2020; 73 A Thind (431_CR119) 2016; 5 431_CR39 K Sugimachi (431_CR127) 2015; 112 Y Xie (431_CR73) 2013; 438 Q Peng (431_CR172) 2013; 34 DL Yuwen (431_CR130) 2017; 21 SA Smith (431_CR35) 2019; 30 JM Pitt (431_CR158) 2014; 193 Y Cao (431_CR43) 2020; 166 KR Jakobsen (431_CR97) 2015; 4 J Castillo (431_CR100) 2018; 29 R Zhao (431_CR140) 2018; 17 H Liu (431_CR46) 2022; 239 431_CR50 DS Rubenich (431_CR69) 2021; 61 H Wu (431_CR129) 2017; 21 Y Li (431_CR142) 2015; 25 D Bellavia (431_CR169) 2017; 7 M Tkach (431_CR61) 2017; 36 N Sun (431_CR17) 2020; 11 ZX Chen (431_CR16) 2020; 11 Y Tian (431_CR45) 2020; 9 A Oszvald (431_CR3) 2020; 38 431_CR134 S Viaud (431_CR9) 2009; 4 431_CR48 S Riedl (431_CR145) 2011; 1808 MF Baietti (431_CR28) 2012; 14 431_CR49 Z Yin (431_CR66) 2019; 38 X Yu (431_CR67) 2019; 10 S Dai (431_CR15) 2005; 11 C Fenselau (431_CR72) 2021; 359 T Hunter (431_CR104) 2000; 100 JM Pitt (431_CR159) 2016; 126 H Wei (431_CR167) 2019; 14 P Song (431_CR29) 2016; 36 E Segura (431_CR59) 2005; 35 F Wei (431_CR57) 2020; 12 M Mikamori (431_CR133) 2017; 7 T Liu (431_CR110) 2014; 44 M Catalano (431_CR152) 2020; 9 NP Hessvik (431_CR30) 2017; 75 SA Melo (431_CR11) 2015; 523 H Peinado (431_CR98) 2012; 18 T Kajimoto (431_CR26) 2013; 4 AM Overmiller (431_CR79) 2017; 31 P Wei (431_CR41) 2020; 9 AM Marleau (431_CR155) 2012; 10 C Alix-Panabières (431_CR86) 2021; 11 LA Diaz Jr (431_CR84) 2014; 32 M Reck (431_CR20) 2016; 375 431_CR141 Y Tomimaru (431_CR115) 2012; 56 W Meng (431_CR165) 2020; 27 D Bellavia (431_CR23) 2017; 7 M Ito (431_CR76) 2021; 35 KC Vallabhaneni (431_CR6) 2016; 11 R Sharma (431_CR148) 2017; 117 E Buscail (431_CR102) 2019; 12 YJ Li (431_CR174) 2021; 19 PC Tumeh (431_CR19) 2014; 515 HD Lee (431_CR68) 2014; 44 ReM Del (431_CR113) 2018; 118 YS Chen (431_CR160) 2020; 32 D Yuwen (431_CR131) 2019; 28 S Schierer (431_CR63) 2018; 1 431_CR71 A Hoshino (431_CR111) 2020; 182 W Sohn (431_CR122) 2015; 47 MM Shi (431_CR162) 2021; 10 M Colombo (431_CR24) 2013; 126 RJ Lobb (431_CR38) 2015; 4 Z Sun (431_CR12) 2018; 17 H Zhang (431_CR151) 2020; 35 C Fu (431_CR156) 2020; 8 Y Zhang (431_CR168) 2022; 20 SR Yoon (431_CR70) 2015; 47 Z Szvicsek (431_CR55) 2019; 76 R Shah (431_CR88) 2018; 379 S Rayamajhi (431_CR22) 2019; 94 D Xiao (431_CR103) 2020; 18 SD Vallabhapurapu (431_CR146) 2015; 6 431_CR117 J Li (431_CR51) 2020; 492 K Trajkovic (431_CR25) 2008; 319 431_CR80 S Munich (431_CR10) 2012; 1 J Hu (431_CR135) 2017; 8 M Xue (431_CR139) 2017; 16 C Thery (431_CR60) 2002; 3 X Zhang (431_CR52) 2021; 28 GK Patel (431_CR173) 2019; 9 Z Sun (431_CR136) 2018; 17 431_CR124 J Lawson (431_CR81) 2019; 58 431_CR120 H Im (431_CR108) 2014; 32 M Tsujiura (431_CR116) 2010; 102 Q Huang (431_CR78) 2021; 517 M Logozzi (431_CR93) 2019; 38 B Yang (431_CR75) 2020; 39 G Liang (431_CR170) 2020; 18 W Liu (431_CR126) 2017; 10 A Hoshino (431_CR33) 2015; 527 431_CR125 P Sharma (431_CR37) 2018; 7 BJ Tauro (431_CR107) 2013; 12 Z Qu (431_CR128) 2017; 8 BJC Quah (431_CR157) 2005; 9 431_CR91 G van Niel (431_CR1) 2018; 19 431_CR92 A Bhan (431_CR137) 2017; 77 F Cappello (431_CR90) 2017; 96 431_CR95 431_CR96 431_CR13 431_CR14 J Li (431_CR101) 2017; 21 C Alix-Panabières (431_CR85) 2016; 6 G Chen (431_CR112) 2018; 560 I Stevic (431_CR132) 2018; 16 S Dai (431_CR163) 2008; 16 SH Lacy (431_CR53) 2019; 60 P Haluska (431_CR154) 2002; 38 H Di (431_CR40) 2020; 10 S Gurung (431_CR34) 2021; 19 B Costa-Silva (431_CR4) 2015; 17 431_CR21 L Langemeyer (431_CR31) 2018; 28 X Mao (431_CR83) 2020; 10 M Sancho-Albero (431_CR32) 2019; 17 Y Miyazoe (431_CR5) 2020; 12 P Mhawech-Fauceglia (431_CR109) 2007; 50 A Caivano (431_CR89) 2015; 36 G Zhu (431_CR77) 2021; 506 KR Qazi (431_CR62) 2009; 113 431_CR105 Z Zhang (431_CR2) 2017; 397 431_CR106 SP Patel (431_CR114) 2015; 14 M Yu (431_CR166) 2019; 110 |
| References_xml | – ident: CR150 – volume: 10 start-page: 9303 year: 2020 end-page: 14 ident: CR40 article-title: Nanozyme-assisted sensitive profiling of exosomal proteins for rapid cancer diagnosis publication-title: Theranostics doi: 10.7150/thno.46568 – volume: 367 start-page: 26 year: 2015 end-page: 33 ident: CR87 article-title: Exosomes: Emerging biomarkers and targets for ovarian cancer publication-title: Cancer Lett doi: 10.1016/j.canlet.2015.07.014 – volume: 11 start-page: 6445 year: 2020 end-page: 53 ident: CR16 article-title: Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis publication-title: J Cancer doi: 10.7150/jca.48531 – volume: 50 start-page: 472 year: 2007 end-page: 83 ident: CR109 article-title: Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique publication-title: Histopathology doi: 10.1111/j.1365-2559.2007.02635.x – volume: 3 year: 2005 ident: CR64 article-title: A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer publication-title: J Transl Med doi: 10.1186/1479-5876-3-9 – ident: CR39 – volume: 182 start-page: 1044 year: 2020 end-page: 61.e1018 ident: CR111 article-title: Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers publication-title: Cell doi: 10.1016/j.cell.2020.07.009 – volume: 61 start-page: 16 year: 2021 end-page: 26 ident: CR69 article-title: Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2021.08.002 – volume: 7 start-page: 1333 year: 2017 end-page: 45 ident: CR23 article-title: Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth publication-title: Theranostics doi: 10.7150/thno.17092 – volume: 17 start-page: 16 year: 2019 ident: CR32 article-title: Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells publication-title: J Nanobiotechnology doi: 10.1186/s12951-018-0437-z – volume: 24 start-page: 766 year: 2014 end-page: 9 ident: CR143 article-title: Double-stranded DNA in exosomes: a novel biomarker in cancer detection publication-title: Cell Res doi: 10.1038/cr.2014.44 – ident: CR80 – volume: 289 start-page: 3869 year: 2014 end-page: 75 ident: CR144 article-title: Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer publication-title: J Biol Chem doi: 10.1074/jbc.C113.532267 – volume: 4 start-page: e4942 year: 2009 ident: CR9 article-title: Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha publication-title: PLoS One doi: 10.1371/journal.pone.0004942 – volume: 17 start-page: 816 year: 2015 end-page: 26 ident: CR4 article-title: Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver publication-title: Nat Cell Biol doi: 10.1038/ncb3169 – ident: CR106 – volume: 17 year: 2018 ident: CR12 article-title: Effect of exosomal miRNA on cancer biology and clinical applications publication-title: Mol Cancer doi: 10.1186/s12943-018-0897-7 – volume: 35 start-page: 89 year: 2005 end-page: 93 ident: CR59 article-title: Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2005.05.003 – volume: 375 start-page: 1823 year: 2016 end-page: 33 ident: CR20 article-title: Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer publication-title: N. Engl J Med doi: 10.1056/NEJMoa1606774 – volume: 38 start-page: 93 year: 2019 end-page: 101 ident: CR93 article-title: Extracellular acidity and increased exosome release as key phenotypes of malignant tumors publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-019-09783-8 – volume: 4 start-page: 27031 year: 2015 ident: CR38 article-title: Optimized exosome isolation protocol for cell culture supernatant and human plasma publication-title: J Extracell Vesicles doi: 10.3402/jev.v4.27031 – volume: 10 start-page: 1802 year: 2016 end-page: 9 ident: CR42 article-title: Integrated Magneto-Electrochemical Sensor for Exosome Analysis publication-title: ACS Nano doi: 10.1021/acsnano.5b07584 – volume: 38 start-page: 310 year: 2019 ident: CR66 article-title: Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-beta signaling pathway publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1313-x – ident: CR71 – volume: 100 start-page: 113 year: 2000 end-page: 27 ident: CR104 article-title: Signaling-2000 and beyond publication-title: Cell doi: 10.1016/S0092-8674(00)81688-8 – volume: 523 start-page: 177 year: 2015 end-page: 82 ident: CR11 article-title: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer publication-title: Nature doi: 10.1038/nature14581 – volume: 7 year: 2017 ident: CR133 article-title: MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma publication-title: Sci Rep doi: 10.1038/srep42339 – volume: 10 start-page: 1528 year: 2009 end-page: 42 ident: CR27 article-title: MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways publication-title: Traffic doi: 10.1111/j.1600-0854.2009.00963.x – volume: 397 start-page: 33 year: 2017 end-page: 42 ident: CR2 article-title: Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis publication-title: Cancer Lett doi: 10.1016/j.canlet.2017.03.004 – ident: CR92 – volume: 9 start-page: 1697028 year: 2020 ident: CR45 article-title: Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry publication-title: J Extracell Vesicles doi: 10.1080/20013078.2019.1697028 – volume: 32 start-page: 1059 year: 2016 end-page: 65 ident: CR118 article-title: Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study publication-title: Pediatr Surg Int doi: 10.1007/s00383-016-3960-8 – volume: 32 start-page: 579 year: 2014 end-page: 86 ident: CR84 article-title: Liquid biopsies: genotyping circulating tumor DNA publication-title: J Clin Oncol doi: 10.1200/JCO.2012.45.2011 – volume: 11 year: 2020 ident: CR17 article-title: Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring publication-title: Nat Commun doi: 10.1038/s41467-020-18311-0 – volume: 492 start-page: 71 year: 2020 end-page: 83 ident: CR51 article-title: Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner publication-title: Cancer Lett doi: 10.1016/j.canlet.2020.08.030 – volume: 1808 start-page: 2638 year: 2011 end-page: 45 ident: CR145 article-title: In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamem.2011.07.026 – volume: 379 start-page: 958 year: 2018 end-page: 66 ident: CR88 article-title: Circulating Extracellular Vesicles in Human Disease publication-title: N. Engl J Med doi: 10.1056/NEJMra1704286 – volume: 20 year: 2022 ident: CR168 article-title: Recent advances in exosome-mediated nucleic acid delivery for cancer therapy publication-title: J Nanobiotechnology doi: 10.1186/s12951-022-01472-z – volume: 73 start-page: 1144 year: 2020 end-page: 54 ident: CR54 article-title: Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis publication-title: J Hepatol doi: 10.1016/j.jhep.2020.04.044 – volume: 32 start-page: 490 year: 2014 end-page: U219. ident: CR18 article-title: Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor publication-title: Nat Biotechnol doi: 10.1038/nbt.2886 – ident: CR36 – volume: 8 year: 2017 ident: CR135 article-title: A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection publication-title: Nat Commun doi: 10.1038/s41467-017-01942-1 – volume: 32 start-page: 490 year: 2014 end-page: 5 ident: CR108 article-title: Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor publication-title: Nat Biotechnol doi: 10.1038/nbt.2886 – volume: 10 start-page: 3843 year: 2017 end-page: 51 ident: CR126 article-title: Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma publication-title: Onco Targets Ther doi: 10.2147/OTT.S140062 – volume: 9 start-page: 643 year: 2005 end-page: 54 ident: CR157 article-title: Maturation of function in dendritic cells for tolerance and immunity publication-title: J CELL MOL MED doi: 10.1111/j.1582-4934.2005.tb00494.x – volume: 77 start-page: 3965 year: 2017 end-page: 81 ident: CR137 article-title: Long Noncoding RNA and Cancer: A New Paradigm publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-2634 – volume: 7 start-page: 2002157 year: 2020 ident: CR82 article-title: Nidogen 1-Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202002157 – volume: 38 start-page: 1685 year: 2002 end-page: 1700 ident: CR154 article-title: Farnesyl transferase inhibitors as anticancer agents publication-title: EUR J CANCER doi: 10.1016/S0959-8049(02)00166-1 – ident: CR91 – volume: 17 year: 2018 ident: CR136 article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment publication-title: Mol Cancer doi: 10.1186/s12943-018-0831-z – volume: 21 start-page: 1228 year: 2017 end-page: 36 ident: CR129 article-title: Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7 publication-title: J Cell Mol Med doi: 10.1111/jcmm.13056 – volume: 75 start-page: 193 year: 2017 end-page: 208 ident: CR30 article-title: Current knowledge on exosome biogenesis and release publication-title: Cell Mol life Sci: CMLS doi: 10.1007/s00018-017-2595-9 – volume: 27 start-page: 585 year: 2020 end-page: 98 ident: CR165 article-title: Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source publication-title: Drug Deliv doi: 10.1080/10717544.2020.1748758 – volume: 19 start-page: 47 year: 2021 ident: CR34 article-title: The exosome journey: from biogenesis to uptake and intracellular signalling publication-title: Cell Commun Signal doi: 10.1186/s12964-021-00730-1 – ident: CR117 – volume: 96 start-page: 93 year: 2017 end-page: 98 ident: CR90 article-title: Exosome levels in human body fluids: A tumor marker by themselves? publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2016.09.010 – volume: 9 year: 2019 ident: CR173 article-title: Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications publication-title: Sci Rep doi: 10.1038/s41598-019-41800-2 – volume: 38 start-page: 81 year: 2019 ident: CR65 article-title: Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1095-1 – volume: 506 start-page: 11 year: 2021 end-page: 22 ident: CR77 article-title: Small extracellular vesicles containing miR-192/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2021.01.006 – volume: 438 start-page: 152 year: 2013 end-page: 5 ident: CR73 article-title: Natural CD8(+)25(+) regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.07.044 – volume: 2014 start-page: 864894 year: 2014 ident: CR121 article-title: Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma publication-title: Biomed Res Int – volume: 8 start-page: 706 year: 2020 ident: CR156 article-title: DC-Based Vaccines for Cancer Immunotherapy publication-title: Vaccines (Basel) doi: 10.3390/vaccines8040706 – volume: 39 start-page: 6529 year: 2020 end-page: 43 ident: CR75 article-title: High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma publication-title: Oncogene doi: 10.1038/s41388-020-01450-5 – ident: CR134 – ident: CR13 – volume: 126 start-page: 1224 year: 2016 end-page: 32 ident: CR159 article-title: Dendritic cell-derived exosomes for cancer therapy publication-title: J CLIN INVEST doi: 10.1172/JCI81137 – volume: 18 start-page: 10 year: 2020 ident: CR170 article-title: Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer publication-title: J Nanobiotechnology doi: 10.1186/s12951-019-0563-2 – volume: 21 start-page: 838 year: 2017 end-page: 47 ident: CR101 article-title: GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer publication-title: J Cell Mol Med doi: 10.1111/jcmm.12941 – volume: 12 start-page: 1395 year: 2019 end-page: 403 ident: CR102 article-title: CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma publication-title: Transl Oncol doi: 10.1016/j.tranon.2019.07.009 – volume: 12 start-page: 12002 year: 2020 end-page: 18 ident: CR57 article-title: Plasma endothelial cells-derived extracellular vesicles promote wound healing in diabetes through YAP and the PI3K/Akt/mTOR pathway publication-title: Aging (Albany NY) doi: 10.18632/aging.103366 – volume: 16 start-page: 782 year: 2008 end-page: 90 ident: CR163 article-title: Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer publication-title: Mol Ther doi: 10.1038/mt.2008.1 – volume: 38 start-page: 291 year: 2020 end-page: 300 ident: CR3 article-title: Extracellular vesicles transmit epithelial growth factor activity in the intestinal stem cell niche publication-title: Stem Cells doi: 10.1002/stem.3113 – ident: CR120 – volume: 193 start-page: 1006 year: 2014 end-page: 11 ident: CR158 article-title: Dendritic Cell-Derived Exosomes as Immunotherapies in the Fight against Cancer publication-title: J IMMUNOL doi: 10.4049/jimmunol.1400703 – volume: 60 start-page: 269 year: 2019 end-page: 78 ident: CR53 article-title: Activated Human Lung Fibroblasts Produce Extracellular Vesicles with Antifibrotic Prostaglandins publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2017-0248OC – volume: 27 start-page: 3062 year: 2019 end-page: 3080.e3011 ident: CR164 article-title: Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles publication-title: Cell Rep doi: 10.1016/j.celrep.2019.05.008 – volume: 19 year: 2021 ident: CR174 article-title: Artificial exosomes for translational nanomedicine publication-title: J Nanobiotechnology doi: 10.1186/s12951-021-00986-2 – volume: 28 start-page: 957 year: 2018 end-page: 70 ident: CR31 article-title: Rab GTPase Function in Endosome and Lysosome Biogenesis publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2018.06.007 – ident: CR125 – volume: 7 start-page: 1435138 year: 2018 ident: CR37 article-title: Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma publication-title: J Extracell Vesicles doi: 10.1080/20013078.2018.1435138 – volume: 14 start-page: 847 year: 2015 end-page: 56 ident: CR114 article-title: PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-14-0983 – volume: 19 start-page: 213 year: 2018 end-page: 28 ident: CR1 article-title: Shedding light on the cell biology of extracellular vesicles publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2017.125 – volume: 44 start-page: 918 year: 2014 end-page: 22 ident: CR110 article-title: Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells publication-title: Int J Oncol doi: 10.3892/ijo.2014.2256 – volume: 35 start-page: 1322 year: 2020 end-page: 30 ident: CR151 article-title: Advances in the discovery of exosome inhibitors in cancer publication-title: J Enzym Inhib Med Chem doi: 10.1080/14756366.2020.1754814 – volume: 10 start-page: 2892 year: 2019 end-page: 906 ident: CR67 article-title: Exosomes from Macrophages Exposed to Apoptotic Breast Cancer Cells Promote Breast Cancer Proliferation and Metastasis publication-title: J Cancer doi: 10.7150/jca.31241 – ident: CR49 – volume: 47 year: 2015 ident: CR70 article-title: Understanding of molecular mechanisms in natural killer cell therapy publication-title: Exp Mol Med doi: 10.1038/emm.2014.114 – volume: 14 start-page: 8603 year: 2019 end-page: 10 ident: CR167 article-title: A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro publication-title: Int J Nanomed doi: 10.2147/IJN.S218988 – volume: 28 start-page: 529 year: 2021 end-page: 42 ident: CR52 article-title: Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling pathway publication-title: Cancer Gene Ther doi: 10.1038/s41417-020-00238-9 – volume: 18 start-page: 300 year: 2020 end-page: 10 ident: CR103 article-title: Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-19-0588 – volume: 36 start-page: 9739 year: 2015 end-page: 52 ident: CR89 article-title: High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders publication-title: Tumour Biol doi: 10.1007/s13277-015-3741-3 – volume: 7 start-page: 1333 year: 2017 end-page: 45 ident: CR169 article-title: Interleukin 3-receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth publication-title: THERANOSTICS doi: 10.7150/thno.17092 – volume: 21 start-page: 493 year: 2017 end-page: 510 ident: CR47 article-title: Current and Emerging Applications of Droplet Digital PCR in Oncology publication-title: Mol Diagn Ther doi: 10.1007/s40291-017-0278-8 – volume: 5 start-page: 31292 year: 2016 ident: CR119 article-title: Exosomal miRNAs as cancer biomarkers and therapeutic targets publication-title: J Extracell Vesicles doi: 10.3402/jev.v5.31292 – volume: 16 year: 2018 ident: CR132 article-title: Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial publication-title: BMC Med doi: 10.1186/s12916-018-1163-y – volume: 117 start-page: 545 year: 2017 end-page: 52 ident: CR148 article-title: Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies publication-title: Br J Cancer doi: 10.1038/bjc.2017.183 – volume: 4 start-page: 2712 year: 2013 ident: CR26 article-title: Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes publication-title: Nat Commun doi: 10.1038/ncomms3712 – volume: 30 start-page: 263 year: 2019 end-page: 72 ident: CR35 article-title: The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery publication-title: Bioconjugate Chem doi: 10.1021/acs.bioconjchem.8b00732 – volume: 527 start-page: 100 year: 2015 end-page: 4 ident: CR56 article-title: Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth publication-title: Nature doi: 10.1038/nature15376 – volume: 359 start-page: 104258 year: 2021 ident: CR72 article-title: Molecular cargo in myeloid-derived suppressor cells and their exosomes publication-title: Cell Immunol doi: 10.1016/j.cellimm.2020.104258 – volume: 113 start-page: 2673 year: 2009 end-page: 83 ident: CR62 article-title: Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism publication-title: Blood doi: 10.1182/blood-2008-04-153536 – volume: 560 start-page: 382 year: 2018 end-page: 6 ident: CR112 article-title: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response publication-title: Nature doi: 10.1038/s41586-018-0392-8 – volume: 94 start-page: 482 year: 2019 end-page: 94 ident: CR22 article-title: Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery publication-title: Acta Biomater doi: 10.1016/j.actbio.2019.05.054 – volume: 21 start-page: 2650 year: 2017 end-page: 8 ident: CR130 article-title: MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer publication-title: Eur Rev Med Pharm Sci – ident: CR21 – volume: 34 start-page: 8521 year: 2013 end-page: 30 ident: CR172 article-title: Preformed albumin corona, a protective coating for nanoparticles based drug delivery system publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.07.102 – volume: 144 start-page: 1444 year: 2019 end-page: 52 ident: CR138 article-title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma publication-title: Int J Cancer doi: 10.1002/ijc.31931 – volume: 11 start-page: 7554 year: 2005 end-page: 63 ident: CR15 article-title: More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-0810 – volume: 12 start-page: 163 year: 2020 end-page: 70 ident: CR5 article-title: Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP-1 cells publication-title: Biomed Rep – ident: CR96 – volume: 32 start-page: 113 year: 2020 end-page: 20 ident: CR160 article-title: Exosomes in clinical trial and their production in compliance with good manufacturing practice publication-title: Ci Ji Yi Xue Za Zhi – volume: 16 year: 2017 ident: CR99 article-title: Role of exosomal proteins in cancer diagnosis publication-title: Mol Cancer doi: 10.1186/s12943-017-0706-8 – ident: CR50 – volume: 58 start-page: 376 year: 2019 end-page: 87 ident: CR81 article-title: Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication publication-title: Mol Carcinog doi: 10.1002/mc.22935 – volume: 108 start-page: 4852 year: 2011 end-page: 7 ident: CR74 article-title: Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1017667108 – volume: 12 start-page: 587 year: 2013 end-page: 98 ident: CR107 article-title: Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids publication-title: Mol Cell Proteom doi: 10.1074/mcp.M112.021303 – volume: 10 start-page: e0141448 year: 2015 ident: CR123 article-title: Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC publication-title: PLoS One doi: 10.1371/journal.pone.0141448 – volume: 6 start-page: 34375 year: 2015 end-page: 88 ident: CR146 article-title: Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium publication-title: Oncotarget doi: 10.18632/oncotarget.6045 – volume: 36 start-page: 2425 year: 2016 end-page: 37 ident: CR29 article-title: Parkin Modulates Endosomal Organization and Function of the Endo-Lysosomal Pathway publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2569-15.2016 – volume: 16 year: 2017 ident: CR139 article-title: Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1 publication-title: Mol Cancer doi: 10.1186/s12943-017-0714-8 – volume: 12 start-page: 5733 year: 2021 ident: CR153 article-title: A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis publication-title: Nat Commun doi: 10.1038/s41467-021-25990-w – volume: 76 start-page: 2463 year: 2019 end-page: 76 ident: CR55 article-title: Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors publication-title: Cell Mol Life Sci doi: 10.1007/s00018-019-03052-1 – ident: CR105 – volume: 6 start-page: 479 year: 2016 end-page: 91 ident: CR85 article-title: Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy publication-title: Cancer Disco doi: 10.1158/2159-8290.CD-15-1483 – volume: 10 start-page: e12031 year: 2020 ident: CR83 article-title: Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells publication-title: J Extracell Vesicles doi: 10.1002/jev2.12031 – volume: 8 start-page: 14395 year: 2017 end-page: 407 ident: CR149 article-title: Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study publication-title: Oncotarget doi: 10.18632/oncotarget.14795 – ident: CR95 – volume: 1 start-page: e201800093 year: 2018 ident: CR63 article-title: Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC publication-title: Life Sci Alliance doi: 10.26508/lsa.201800093 – volume: 10 start-page: e12134-n/a year: 2021 ident: CR162 article-title: Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles publication-title: J Extracell Vesicles doi: 10.1002/jev2.12134 – volume: 205 start-page: 2916 year: 2020 end-page: 25 ident: CR8 article-title: Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183 publication-title: J Immunol doi: 10.4049/jimmunol.1901104 – volume: 3 start-page: 1156 year: 2002 end-page: 62 ident: CR60 article-title: Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes publication-title: Nat Immunol doi: 10.1038/ni854 – volume: 110 start-page: 3173 year: 2019 end-page: 82 ident: CR166 article-title: Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells publication-title: Cancer Sci doi: 10.1111/cas.14181 – volume: 10 start-page: 134 year: 2012 ident: CR155 article-title: Exosome removal as a therapeutic adjuvant in cancer publication-title: J Transl Med doi: 10.1186/1479-5876-10-134 – volume: 517 start-page: 1 year: 2021 end-page: 13 ident: CR78 article-title: Small extracellular vesicle-packaged TGFbeta1 promotes the reprogramming of normal fibroblasts into cancer-associated fibroblasts by regulating fibronectin in head and neck squamous cell carcinoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2021.05.017 – volume: 11 start-page: 858 year: 2021 end-page: 73 ident: CR86 article-title: Liquid Biopsy: From Discovery to Clinical Application publication-title: Cancer Disco doi: 10.1158/2159-8290.CD-20-1311 – volume: 14 start-page: 2847 year: 2019 end-page: 59 ident: CR161 article-title: Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy publication-title: Int J Nanomed doi: 10.2147/IJN.S200036 – volume: 290 start-page: 30684 year: 2015 end-page: 96 ident: CR58 article-title: Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration publication-title: J Biol Chem doi: 10.1074/jbc.M115.671735 – volume: 44 start-page: 1156 year: 2014 end-page: 69 ident: CR68 article-title: Exosomes derived from human macrophages suppress endothelial cell migration by controlling integrin trafficking publication-title: Eur J Immunol doi: 10.1002/eji.201343660 – ident: CR14 – volume: 9 start-page: 1703244 year: 2020 ident: CR152 article-title: Inhibiting extracellular vesicles formation and release: a review of EV inhibitors publication-title: J Extracell Vesicles doi: 10.1080/20013078.2019.1703244 – volume: 166 start-page: 112452 year: 2020 ident: CR43 article-title: Identification of programmed death ligand-1 positive exosomes in breast cancer based on DNA amplification-responsive metal-organic frameworks publication-title: Biosens Bioelectron doi: 10.1016/j.bios.2020.112452 – volume: 31 start-page: 3412 year: 2017 end-page: 24 ident: CR79 article-title: Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes publication-title: FASEB J doi: 10.1096/fj.201601138RR – volume: 47 year: 2015 ident: CR122 article-title: Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma publication-title: Exp Mol Med doi: 10.1038/emm.2015.68 – volume: 515 start-page: 568 year: 2014 end-page: 71 ident: CR19 article-title: PD-1 blockade induces responses by inhibiting adaptive immune resistance publication-title: Nature doi: 10.1038/nature13954 – volume: 126 start-page: 5553 year: 2013 end-page: 65. ident: CR24 article-title: Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles publication-title: J Cell Sci – volume: 18 start-page: 883 year: 2012 end-page: 91 ident: CR98 article-title: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET publication-title: Nat Med doi: 10.1038/nm.2753 – volume: 9 start-page: 1809765 year: 2020 ident: CR41 article-title: Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer publication-title: J Extracell Vesicles doi: 10.1080/20013078.2020.1809765 – volume: 239 start-page: 123089 year: 2022 ident: CR46 article-title: Single-particle analysis of tear fluid reveals abundant presence of tissue factor-exposing extracellular vesicles with strong coagulation activity publication-title: Talanta doi: 10.1016/j.talanta.2021.123089 – volume: 28 start-page: 163 year: 2019 end-page: 73 ident: CR131 article-title: Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-18-0569 – volume: 527 start-page: 329 year: 2015 end-page: 35 ident: CR33 article-title: Tumour exosome integrins determine organotropic metastasis publication-title: Nature doi: 10.1038/nature15756 – ident: CR124 – volume: 36 start-page: 3012 year: 2017 end-page: 28 ident: CR61 article-title: Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes publication-title: EMBO J doi: 10.15252/embj.201696003 – ident: CR48 – volume: 10 start-page: 728616 year: 2022 ident: CR171 article-title: Exosomes as Drug Carriers in Anti-Cancer Therapy publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2022.728616 – volume: 102 start-page: 1174 year: 2010 end-page: 9 ident: CR116 article-title: Circulating microRNAs in plasma of patients with gastric cancers publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605608 – volume: 14 start-page: 677 year: 2012 end-page: 85 ident: CR28 article-title: Syndecan-syntenin-ALIX regulates the biogenesis of exosomes publication-title: Nat Cell Biol doi: 10.1038/ncb2502 – volume: 56 start-page: 167 year: 2012 end-page: 75 ident: CR115 article-title: Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2011.04.026 – volume: 8 start-page: 80666 year: 2017 end-page: 78 ident: CR128 article-title: Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis publication-title: Oncotarget doi: 10.18632/oncotarget.20881 – volume: 319 start-page: 1244 year: 2008 end-page: 7 ident: CR25 article-title: Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes publication-title: Science doi: 10.1126/science.1153124 – volume: 29 start-page: 223 year: 2018 end-page: 9 ident: CR100 article-title: Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients publication-title: Ann Oncol doi: 10.1093/annonc/mdx542 – volume: 118 start-page: 820 year: 2018 end-page: 4 ident: CR113 article-title: PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC publication-title: Br J Cancer doi: 10.1038/bjc.2018.9 – volume: 132 start-page: 756 year: 2009 end-page: 62 ident: CR147 article-title: Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters publication-title: Am J Clin Pathol doi: 10.1309/AJCPAVFA8J3KHPRS – volume: 11 start-page: e0166027 year: 2016 ident: CR6 article-title: Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication publication-title: PLoS One doi: 10.1371/journal.pone.0166027 – volume: 17 year: 2018 ident: CR140 article-title: Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer publication-title: Mol Cancer doi: 10.1186/s12943-018-0817-x – volume: 35 start-page: e21505 year: 2021 ident: CR76 article-title: Proteomic and phospholipidomic characterization of extracellular vesicles inducing tumor microenvironment in Epstein-Barr virus-associated lymphomas publication-title: FASEB J doi: 10.1096/fj.202002730R – volume: 1 start-page: 1074 year: 2012 end-page: 83 ident: CR10 article-title: Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands publication-title: Oncoimmunology doi: 10.4161/onci.20897 – ident: CR141 – volume: 11 year: 2020 ident: CR7 article-title: Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice publication-title: Nat Commun doi: 10.1038/s41467-020-15569-2 – volume: 5 year: 2014 ident: CR44 article-title: Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen publication-title: Nat Commun doi: 10.1038/ncomms4591 – volume: 4 start-page: 26659 year: 2015 ident: CR97 article-title: Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma publication-title: J Extracell Vesicles doi: 10.3402/jev.v4.26659 – volume: 14 start-page: e0215990 year: 2019 ident: CR94 article-title: Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy publication-title: PLoS One doi: 10.1371/journal.pone.0215990 – volume: 112 start-page: 532 year: 2015 end-page: 8 ident: CR127 article-title: Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation publication-title: Br J Cancer doi: 10.1038/bjc.2014.621 – volume: 25 start-page: 981 year: 2015 end-page: 4 ident: CR142 article-title: Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis publication-title: Cell Res doi: 10.1038/cr.2015.82 – volume: 47 year: 2015 ident: 431_CR122 publication-title: Exp Mol Med doi: 10.1038/emm.2015.68 – volume: 126 start-page: 1224 year: 2016 ident: 431_CR159 publication-title: J CLIN INVEST doi: 10.1172/JCI81137 – volume: 76 start-page: 2463 year: 2019 ident: 431_CR55 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-019-03052-1 – ident: 431_CR48 doi: 10.1038/s41467-018-07947-8 – ident: 431_CR106 doi: 10.1038/s41467-020-18311-0 – volume: 61 start-page: 16 year: 2021 ident: 431_CR69 publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2021.08.002 – ident: 431_CR91 doi: 10.1080/2162402X.2019.1593805 – volume: 4 start-page: 26659 year: 2015 ident: 431_CR97 publication-title: J Extracell Vesicles doi: 10.3402/jev.v4.26659 – volume: 94 start-page: 482 year: 2019 ident: 431_CR22 publication-title: Acta Biomater doi: 10.1016/j.actbio.2019.05.054 – volume: 10 start-page: 134 year: 2012 ident: 431_CR155 publication-title: J Transl Med doi: 10.1186/1479-5876-10-134 – volume: 17 year: 2018 ident: 431_CR136 publication-title: Mol Cancer doi: 10.1186/s12943-018-0831-z – volume: 60 start-page: 269 year: 2019 ident: 431_CR53 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2017-0248OC – ident: 431_CR95 doi: 10.3390/cancers11030429 – volume: 21 start-page: 1228 year: 2017 ident: 431_CR129 publication-title: J Cell Mol Med doi: 10.1111/jcmm.13056 – volume: 29 start-page: 223 year: 2018 ident: 431_CR100 publication-title: Ann Oncol doi: 10.1093/annonc/mdx542 – volume: 21 start-page: 2650 year: 2017 ident: 431_CR130 publication-title: Eur Rev Med Pharm Sci – volume: 2014 start-page: 864894 year: 2014 ident: 431_CR121 publication-title: Biomed Res Int – volume: 6 start-page: 34375 year: 2015 ident: 431_CR146 publication-title: Oncotarget doi: 10.18632/oncotarget.6045 – ident: 431_CR21 doi: 10.4049/jimmunol.1400703 – ident: 431_CR36 doi: 10.3402/jev.v2i0.20360 – volume: 38 start-page: 310 year: 2019 ident: 431_CR66 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1313-x – volume: 379 start-page: 958 year: 2018 ident: 431_CR88 publication-title: N. Engl J Med doi: 10.1056/NEJMra1704286 – ident: 431_CR96 doi: 10.3390/cancers11101449 – volume: 9 start-page: 1697028 year: 2020 ident: 431_CR45 publication-title: J Extracell Vesicles doi: 10.1080/20013078.2019.1697028 – volume: 10 start-page: 2892 year: 2019 ident: 431_CR67 publication-title: J Cancer doi: 10.7150/jca.31241 – volume: 9 year: 2019 ident: 431_CR173 publication-title: Sci Rep doi: 10.1038/s41598-019-41800-2 – volume: 36 start-page: 2425 year: 2016 ident: 431_CR29 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2569-15.2016 – volume: 108 start-page: 4852 year: 2011 ident: 431_CR74 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1017667108 – volume: 9 start-page: 643 year: 2005 ident: 431_CR157 publication-title: J CELL MOL MED doi: 10.1111/j.1582-4934.2005.tb00494.x – volume: 20 year: 2022 ident: 431_CR168 publication-title: J Nanobiotechnology doi: 10.1186/s12951-022-01472-z – volume: 17 start-page: 816 year: 2015 ident: 431_CR4 publication-title: Nat Cell Biol doi: 10.1038/ncb3169 – volume: 8 start-page: 80666 year: 2017 ident: 431_CR128 publication-title: Oncotarget doi: 10.18632/oncotarget.20881 – volume: 39 start-page: 6529 year: 2020 ident: 431_CR75 publication-title: Oncogene doi: 10.1038/s41388-020-01450-5 – volume: 11 year: 2020 ident: 431_CR7 publication-title: Nat Commun doi: 10.1038/s41467-020-15569-2 – volume: 289 start-page: 3869 year: 2014 ident: 431_CR144 publication-title: J Biol Chem doi: 10.1074/jbc.C113.532267 – volume: 117 start-page: 545 year: 2017 ident: 431_CR148 publication-title: Br J Cancer doi: 10.1038/bjc.2017.183 – volume: 77 start-page: 3965 year: 2017 ident: 431_CR137 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-2634 – ident: 431_CR134 doi: 10.1038/s41388-019-0771-0 – volume: 9 start-page: 1809765 year: 2020 ident: 431_CR41 publication-title: J Extracell Vesicles doi: 10.1080/20013078.2020.1809765 – volume: 31 start-page: 3412 year: 2017 ident: 431_CR79 publication-title: FASEB J doi: 10.1096/fj.201601138RR – volume: 1808 start-page: 2638 year: 2011 ident: 431_CR145 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamem.2011.07.026 – volume: 34 start-page: 8521 year: 2013 ident: 431_CR172 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.07.102 – volume: 1 start-page: e201800093 year: 2018 ident: 431_CR63 publication-title: Life Sci Alliance doi: 10.26508/lsa.201800093 – ident: 431_CR124 doi: 10.1002/jcb.27165 – volume: 17 year: 2018 ident: 431_CR12 publication-title: Mol Cancer doi: 10.1186/s12943-018-0897-7 – ident: 431_CR141 doi: 10.1186/s12943-019-1041-z – volume: 16 year: 2017 ident: 431_CR139 publication-title: Mol Cancer doi: 10.1186/s12943-017-0714-8 – volume: 527 start-page: 100 year: 2015 ident: 431_CR56 publication-title: Nature doi: 10.1038/nature15376 – volume: 319 start-page: 1244 year: 2008 ident: 431_CR25 publication-title: Science doi: 10.1126/science.1153124 – volume: 375 start-page: 1823 year: 2016 ident: 431_CR20 publication-title: N. Engl J Med doi: 10.1056/NEJMoa1606774 – volume: 14 start-page: 677 year: 2012 ident: 431_CR28 publication-title: Nat Cell Biol doi: 10.1038/ncb2502 – volume: 110 start-page: 3173 year: 2019 ident: 431_CR166 publication-title: Cancer Sci doi: 10.1111/cas.14181 – volume: 5 year: 2014 ident: 431_CR44 publication-title: Nat Commun doi: 10.1038/ncomms4591 – volume: 10 start-page: 3843 year: 2017 ident: 431_CR126 publication-title: Onco Targets Ther doi: 10.2147/OTT.S140062 – volume: 367 start-page: 26 year: 2015 ident: 431_CR87 publication-title: Cancer Lett doi: 10.1016/j.canlet.2015.07.014 – volume: 18 start-page: 300 year: 2020 ident: 431_CR103 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-19-0588 – volume: 397 start-page: 33 year: 2017 ident: 431_CR2 publication-title: Cancer Lett doi: 10.1016/j.canlet.2017.03.004 – volume: 11 start-page: 7554 year: 2005 ident: 431_CR15 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-0810 – volume: 28 start-page: 957 year: 2018 ident: 431_CR31 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2018.06.007 – volume: 24 start-page: 766 year: 2014 ident: 431_CR143 publication-title: Cell Res doi: 10.1038/cr.2014.44 – volume: 19 year: 2021 ident: 431_CR174 publication-title: J Nanobiotechnology doi: 10.1186/s12951-021-00986-2 – volume: 44 start-page: 1156 year: 2014 ident: 431_CR68 publication-title: Eur J Immunol doi: 10.1002/eji.201343660 – volume: 32 start-page: 1059 year: 2016 ident: 431_CR118 publication-title: Pediatr Surg Int doi: 10.1007/s00383-016-3960-8 – volume: 27 start-page: 585 year: 2020 ident: 431_CR165 publication-title: Drug Deliv doi: 10.1080/10717544.2020.1748758 – volume: 27 start-page: 3062 year: 2019 ident: 431_CR164 publication-title: Cell Rep doi: 10.1016/j.celrep.2019.05.008 – volume: 1 start-page: 1074 year: 2012 ident: 431_CR10 publication-title: Oncoimmunology doi: 10.4161/onci.20897 – volume: 32 start-page: 113 year: 2020 ident: 431_CR160 publication-title: Ci Ji Yi Xue Za Zhi – ident: 431_CR50 doi: 10.1186/s12943-022-01509-9 – volume: 32 start-page: 490 year: 2014 ident: 431_CR108 publication-title: Nat Biotechnol doi: 10.1038/nbt.2886 – volume: 35 start-page: 1322 year: 2020 ident: 431_CR151 publication-title: J Enzym Inhib Med Chem doi: 10.1080/14756366.2020.1754814 – volume: 28 start-page: 163 year: 2019 ident: 431_CR131 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-18-0569 – volume: 527 start-page: 329 year: 2015 ident: 431_CR33 publication-title: Nature doi: 10.1038/nature15756 – volume: 182 start-page: 1044 year: 2020 ident: 431_CR111 publication-title: Cell doi: 10.1016/j.cell.2020.07.009 – volume: 18 start-page: 10 year: 2020 ident: 431_CR170 publication-title: J Nanobiotechnology doi: 10.1186/s12951-019-0563-2 – volume: 14 start-page: 8603 year: 2019 ident: 431_CR167 publication-title: Int J Nanomed doi: 10.2147/IJN.S218988 – volume: 8 start-page: 14395 year: 2017 ident: 431_CR149 publication-title: Oncotarget doi: 10.18632/oncotarget.14795 – volume: 50 start-page: 472 year: 2007 ident: 431_CR109 publication-title: Histopathology doi: 10.1111/j.1365-2559.2007.02635.x – ident: 431_CR125 doi: 10.1002/jcb.26650 – volume: 4 start-page: 2712 year: 2013 ident: 431_CR26 publication-title: Nat Commun doi: 10.1038/ncomms3712 – volume: 560 start-page: 382 year: 2018 ident: 431_CR112 publication-title: Nature doi: 10.1038/s41586-018-0392-8 – volume: 100 start-page: 113 year: 2000 ident: 431_CR104 publication-title: Cell doi: 10.1016/S0092-8674(00)81688-8 – volume: 506 start-page: 11 year: 2021 ident: 431_CR77 publication-title: Cancer Lett doi: 10.1016/j.canlet.2021.01.006 – volume: 16 year: 2018 ident: 431_CR132 publication-title: BMC Med doi: 10.1186/s12916-018-1163-y – volume: 11 start-page: 6445 year: 2020 ident: 431_CR16 publication-title: J Cancer doi: 10.7150/jca.48531 – volume: 17 start-page: 16 year: 2019 ident: 431_CR32 publication-title: J Nanobiotechnology doi: 10.1186/s12951-018-0437-z – volume: 36 start-page: 9739 year: 2015 ident: 431_CR89 publication-title: Tumour Biol doi: 10.1007/s13277-015-3741-3 – volume: 10 start-page: 728616 year: 2022 ident: 431_CR171 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2022.728616 – ident: 431_CR150 doi: 10.7150/thno.21945 – ident: 431_CR80 doi: 10.3390/ijms23042180 – volume: 359 start-page: 104258 year: 2021 ident: 431_CR72 publication-title: Cell Immunol doi: 10.1016/j.cellimm.2020.104258 – volume: 12 start-page: 5733 year: 2021 ident: 431_CR153 publication-title: Nat Commun doi: 10.1038/s41467-021-25990-w – volume: 515 start-page: 568 year: 2014 ident: 431_CR19 publication-title: Nature doi: 10.1038/nature13954 – volume: 290 start-page: 30684 year: 2015 ident: 431_CR58 publication-title: J Biol Chem doi: 10.1074/jbc.M115.671735 – volume: 193 start-page: 1006 year: 2014 ident: 431_CR158 publication-title: J IMMUNOL doi: 10.4049/jimmunol.1400703 – volume: 11 start-page: e0166027 year: 2016 ident: 431_CR6 publication-title: PLoS One doi: 10.1371/journal.pone.0166027 – volume: 25 start-page: 981 year: 2015 ident: 431_CR142 publication-title: Cell Res doi: 10.1038/cr.2015.82 – volume: 11 year: 2020 ident: 431_CR17 publication-title: Nat Commun doi: 10.1038/s41467-020-18311-0 – volume: 56 start-page: 167 year: 2012 ident: 431_CR115 publication-title: J Hepatol doi: 10.1016/j.jhep.2011.04.026 – volume: 102 start-page: 1174 year: 2010 ident: 431_CR116 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605608 – volume: 10 start-page: 9303 year: 2020 ident: 431_CR40 publication-title: Theranostics doi: 10.7150/thno.46568 – volume: 8 start-page: 706 year: 2020 ident: 431_CR156 publication-title: Vaccines (Basel) doi: 10.3390/vaccines8040706 – volume: 166 start-page: 112452 year: 2020 ident: 431_CR43 publication-title: Biosens Bioelectron doi: 10.1016/j.bios.2020.112452 – volume: 35 start-page: e21505 year: 2021 ident: 431_CR76 publication-title: FASEB J doi: 10.1096/fj.202002730R – ident: 431_CR49 doi: 10.1021/jacs.9b13960 – volume: 126 start-page: 5553 year: 2013 ident: 431_CR24 publication-title: J Cell Sci – ident: 431_CR120 doi: 10.1126/science.aau6977 – volume: 4 start-page: e4942 year: 2009 ident: 431_CR9 publication-title: PLoS One doi: 10.1371/journal.pone.0004942 – volume: 12 start-page: 12002 year: 2020 ident: 431_CR57 publication-title: Aging (Albany NY) doi: 10.18632/aging.103366 – volume: 10 start-page: e0141448 year: 2015 ident: 431_CR123 publication-title: PLoS One doi: 10.1371/journal.pone.0141448 – volume: 75 start-page: 193 year: 2017 ident: 431_CR30 publication-title: Cell Mol life Sci: CMLS doi: 10.1007/s00018-017-2595-9 – volume: 14 start-page: e0215990 year: 2019 ident: 431_CR94 publication-title: PLoS One doi: 10.1371/journal.pone.0215990 – volume: 6 start-page: 479 year: 2016 ident: 431_CR85 publication-title: Cancer Disco doi: 10.1158/2159-8290.CD-15-1483 – volume: 36 start-page: 3012 year: 2017 ident: 431_CR61 publication-title: EMBO J doi: 10.15252/embj.201696003 – volume: 4 start-page: 27031 year: 2015 ident: 431_CR38 publication-title: J Extracell Vesicles doi: 10.3402/jev.v4.27031 – ident: 431_CR71 doi: 10.1126/scitranslmed.aaz3426 – volume: 21 start-page: 838 year: 2017 ident: 431_CR101 publication-title: J Cell Mol Med doi: 10.1111/jcmm.12941 – volume: 7 start-page: 1333 year: 2017 ident: 431_CR169 publication-title: THERANOSTICS doi: 10.7150/thno.17092 – volume: 38 start-page: 1685 year: 2002 ident: 431_CR154 publication-title: EUR J CANCER doi: 10.1016/S0959-8049(02)00166-1 – volume: 73 start-page: 1144 year: 2020 ident: 431_CR54 publication-title: J Hepatol doi: 10.1016/j.jhep.2020.04.044 – volume: 32 start-page: 490 year: 2014 ident: 431_CR18 publication-title: Nat Biotechnol doi: 10.1038/nbt.2886 – volume: 44 start-page: 918 year: 2014 ident: 431_CR110 publication-title: Int J Oncol doi: 10.3892/ijo.2014.2256 – volume: 10 start-page: 1528 year: 2009 ident: 431_CR27 publication-title: Traffic doi: 10.1111/j.1600-0854.2009.00963.x – volume: 12 start-page: 1395 year: 2019 ident: 431_CR102 publication-title: Transl Oncol doi: 10.1016/j.tranon.2019.07.009 – volume: 8 year: 2017 ident: 431_CR135 publication-title: Nat Commun doi: 10.1038/s41467-017-01942-1 – ident: 431_CR14 doi: 10.3390/cancers11030429 – volume: 30 start-page: 263 year: 2019 ident: 431_CR35 publication-title: Bioconjugate Chem doi: 10.1021/acs.bioconjchem.8b00732 – volume: 7 start-page: 2002157 year: 2020 ident: 431_CR82 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202002157 – volume: 11 start-page: 858 year: 2021 ident: 431_CR86 publication-title: Cancer Disco doi: 10.1158/2159-8290.CD-20-1311 – volume: 9 start-page: 1703244 year: 2020 ident: 431_CR152 publication-title: J Extracell Vesicles doi: 10.1080/20013078.2019.1703244 – volume: 16 year: 2017 ident: 431_CR99 publication-title: Mol Cancer doi: 10.1186/s12943-017-0706-8 – volume: 96 start-page: 93 year: 2017 ident: 431_CR90 publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2016.09.010 – volume: 14 start-page: 2847 year: 2019 ident: 431_CR161 publication-title: Int J Nanomed doi: 10.2147/IJN.S200036 – volume: 14 start-page: 847 year: 2015 ident: 431_CR114 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-14-0983 – volume: 239 start-page: 123089 year: 2022 ident: 431_CR46 publication-title: Talanta doi: 10.1016/j.talanta.2021.123089 – volume: 10 start-page: e12031 year: 2020 ident: 431_CR83 publication-title: J Extracell Vesicles doi: 10.1002/jev2.12031 – volume: 38 start-page: 291 year: 2020 ident: 431_CR3 publication-title: Stem Cells doi: 10.1002/stem.3113 – volume: 492 start-page: 71 year: 2020 ident: 431_CR51 publication-title: Cancer Lett doi: 10.1016/j.canlet.2020.08.030 – volume: 18 start-page: 883 year: 2012 ident: 431_CR98 publication-title: Nat Med doi: 10.1038/nm.2753 – ident: 431_CR39 doi: 10.1080/20013078.2020.1791450 – volume: 144 start-page: 1444 year: 2019 ident: 431_CR138 publication-title: Int J Cancer doi: 10.1002/ijc.31931 – ident: 431_CR13 doi: 10.3402/jev.v4.26659 – volume: 113 start-page: 2673 year: 2009 ident: 431_CR62 publication-title: Blood doi: 10.1182/blood-2008-04-153536 – volume: 3 year: 2005 ident: 431_CR64 publication-title: J Transl Med doi: 10.1186/1479-5876-3-9 – volume: 32 start-page: 579 year: 2014 ident: 431_CR84 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.45.2011 – ident: 431_CR117 doi: 10.3390/jcm5030030 – volume: 7 year: 2017 ident: 431_CR133 publication-title: Sci Rep doi: 10.1038/srep42339 – volume: 523 start-page: 177 year: 2015 ident: 431_CR11 publication-title: Nature doi: 10.1038/nature14581 – volume: 438 start-page: 152 year: 2013 ident: 431_CR73 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.07.044 – volume: 205 start-page: 2916 year: 2020 ident: 431_CR8 publication-title: J Immunol doi: 10.4049/jimmunol.1901104 – volume: 10 start-page: e12134-n/a year: 2021 ident: 431_CR162 publication-title: J Extracell Vesicles doi: 10.1002/jev2.12134 – ident: 431_CR105 doi: 10.1073/pnas.1618088114 – volume: 12 start-page: 163 year: 2020 ident: 431_CR5 publication-title: Biomed Rep – volume: 132 start-page: 756 year: 2009 ident: 431_CR147 publication-title: Am J Clin Pathol doi: 10.1309/AJCPAVFA8J3KHPRS – volume: 3 start-page: 1156 year: 2002 ident: 431_CR60 publication-title: Nat Immunol doi: 10.1038/ni854 – volume: 38 start-page: 81 year: 2019 ident: 431_CR65 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1095-1 – ident: 431_CR92 doi: 10.1158/1078-0432.CCR-18-1941 – volume: 118 start-page: 820 year: 2018 ident: 431_CR113 publication-title: Br J Cancer doi: 10.1038/bjc.2018.9 – volume: 19 start-page: 47 year: 2021 ident: 431_CR34 publication-title: Cell Commun Signal doi: 10.1186/s12964-021-00730-1 – volume: 12 start-page: 587 year: 2013 ident: 431_CR107 publication-title: Mol Cell Proteom doi: 10.1074/mcp.M112.021303 – volume: 19 start-page: 213 year: 2018 ident: 431_CR1 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2017.125 – volume: 35 start-page: 89 year: 2005 ident: 431_CR59 publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2005.05.003 – volume: 10 start-page: 1802 year: 2016 ident: 431_CR42 publication-title: ACS Nano doi: 10.1021/acsnano.5b07584 – volume: 17 year: 2018 ident: 431_CR140 publication-title: Mol Cancer doi: 10.1186/s12943-018-0817-x – volume: 5 start-page: 31292 year: 2016 ident: 431_CR119 publication-title: J Extracell Vesicles doi: 10.3402/jev.v5.31292 – volume: 47 year: 2015 ident: 431_CR70 publication-title: Exp Mol Med doi: 10.1038/emm.2014.114 – volume: 58 start-page: 376 year: 2019 ident: 431_CR81 publication-title: Mol Carcinog doi: 10.1002/mc.22935 – volume: 21 start-page: 493 year: 2017 ident: 431_CR47 publication-title: Mol Diagn Ther doi: 10.1007/s40291-017-0278-8 – volume: 517 start-page: 1 year: 2021 ident: 431_CR78 publication-title: Cancer Lett doi: 10.1016/j.canlet.2021.05.017 – volume: 7 start-page: 1333 year: 2017 ident: 431_CR23 publication-title: Theranostics doi: 10.7150/thno.17092 – volume: 38 start-page: 93 year: 2019 ident: 431_CR93 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-019-09783-8 – volume: 112 start-page: 532 year: 2015 ident: 431_CR127 publication-title: Br J Cancer doi: 10.1038/bjc.2014.621 – volume: 7 start-page: 1435138 year: 2018 ident: 431_CR37 publication-title: J Extracell Vesicles doi: 10.1080/20013078.2018.1435138 – volume: 28 start-page: 529 year: 2021 ident: 431_CR52 publication-title: Cancer Gene Ther doi: 10.1038/s41417-020-00238-9 – volume: 16 start-page: 782 year: 2008 ident: 431_CR163 publication-title: Mol Ther doi: 10.1038/mt.2008.1 |
| SSID | ssj0000561655 |
| Score | 2.6090438 |
| SecondaryResourceType | review_article |
| Snippet | Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular... Abstract Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional... |
| SourceID | doaj pubmedcentral proquest crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 54 |
| SubjectTerms | 631/67 631/67/1857 Apoptosis Biomarkers Cancer Cell Biology Drug development Endocytosis Exosomes Extracellular vesicles Human Genetics Immunosuppressive agents Internal Medicine Lipid metabolism Medicine Medicine & Public Health Oncology Review Review Article Therapeutic targets |
| SummonAdditionalLinks | – databaseName: Science Database (ProQuest) dbid: M2P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9UwDI9gIMSF8SkKGyoSN4jWNMlrckKwD3HZNCGQdovSOGGTRjvat4k_nzjNe6OT2IVjE7tNYzv5KXZsQt5BFUJohaQR2nsq4oZLrVSailY7DnUE2BBSsYnm6EidnOjjfOA25rDK1ZqYFmroHZ6R79QNw0zvWsqPF78oVo1C72ouoXGX3IvIhmFI12F9vD5jQXS8kDLflam42hkFOuYohrCjD4xROduPUtr-Gda8GSl5w12adqGDzf8d_2PyKOPP8tOkME_IHd89JQ8Os4f9Gfm6_7sf-59-LG0HpUOdGEpa7k0ReZEptWNUV37E-_sY4jNMHH_d5yqv_Cl-5Dn5frD_bfcLzXUXqJOKL6lsmFOtCw2zEGwlAmsDAw1OeeZ1wBLV1tZQVV7xRROiUNsATaU8VA5aVfMXZKPrO_-SlKC8d63kWumF0BFbxDdEzoi7XKQVuiBsNfvG5aTkWBvj3CTnOFdmkpiJEjNJYkYW5P2a52JKyXEr9WcU6poS02mnhn74YbJ1Ggg8wibGPWu9CA50LW1juVVRdwEEFGRrJVSTbXw01xItyNt1d7ROdLnYzveXiUYKrqSuCtLMVGk2oHlPd3aa8nxr0UT8Fufow0rprj_-7x9-dftYX5OHdVJ_TZncIhvL4dJvk_vuank2Dm-S_fwBHXQkCg priority: 102 providerName: ProQuest |
| Title | Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle |
| URI | https://link.springer.com/article/10.1038/s41389-022-00431-5 https://www.proquest.com/docview/2714788955 https://www.proquest.com/docview/2715438590 https://pubmed.ncbi.nlm.nih.gov/PMC9477829 https://doaj.org/article/df391013e1be4fcd925a7a3a8441dd4d |
| Volume | 11 |
| WOSCitedRecordID | wos000854766400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2157-9024 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000561655 issn: 2157-9024 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2157-9024 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000561655 issn: 2157-9024 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LbtQw0IKCUC8VT7FQVkHiBlbt2F7bxz62gsOuogqk5WQ5fqiVIIs226onvp2xk102lYALF0uJZ_yYGWcmmvEMQu88iTHWXGAw7QPmoHCxFUpjXmvHfAkGto-52IScz9VioaudUl8pJqxLD9wR7shHBhqNskDrwKPzuhRWWmYVDOs99-nrS6Te-ZnqsnpP6ESI_pYMYeqo5cklh1PwevJ-USwGmign7B9YmXdjJO84SrP-OX-MDnrDsTjuFvwE3QvNU_Ro1rvGn6GL6e2yXX4PbWEbX7jEzFWBi7MulA6Q8vsUjtU_pov3KTZn1WHsXMQqbsJlmuQ5-nI-_Xz6EfcFE7ATiq2xkNSp2kVJrY-W8EjrSL32TgUadEy1pa0tPSFBsYmMwI06eklU8MT5WpXsBdprlk14iQqvQnC1YFrpCddgFMAIgAkGkwNYrkeIbohnXJ9NPBW1-GayV5sp0xHcAMFNJrgRI_R-i_Ojy6XxV-iTxJMtZMqDnV-AdJheOsy_pGOEDjccNf3hbE0paSoaoAXM8XbbDccq-UpsE5bXGUZwpoQmIyQHkjBY0LCnubrMCbo1l2B4AY0-bGTm9-R_3vCr_7Hh12i_zDKuMRWHaG-9ug5v0EN3s75qV2N0Xy5kbtUYPTiZzquLcT440M7KKrUytz-n0F99mlVffwFxxR7I |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBQEX3ohAgSDBCazGsb2xDwgBbdWq7apCRerNJH7QSpCUzbbAn-I34nGSLalEbz1wjB-JH5_HXzzjGYAXNvPeV1yQQO0d4WHDJaWQivBKGWbzQLCtj8EmiulUHhyovSX4PdyFQbPKQSZGQW0bg2fkq3lB0dO7EuLt8XeCUaNQuzqE0Ohgse1-_Qi_bO2brbUwvy_zfGN9_8Mm6aMKECMkmxNRUCMr4wtaWl9m3NPKU6uskY465TEAc1nmNsucZJPChyZX3haZdDYztpLo6CCI_CscPYuhqWC-tzjTQTY-EaK_m5MxudpyVAQSNJlHnRslYrT_xTABI2573jLznHo27nobt_638boNN3t-nb7rFsQdWHL1Xbi221sQ3IOP6z-btvnm2rSsbWoQ87OUpGudxWGoFNPRaq1_RP8EaMI062r8dV8tPXWH-JH78OlSevQAluumdg8htdI5UwmmpJpwFbhTeEOoGXilCWW5SoAOs61N73QdY3981VH5z6TuEKIDQnREiBYJvFrUOe5cjlxY-j2CaFES3YXHhGb2RffSR1vPAi2kzNHKcW-sykVZlKyUYW1ay20CKwOIdC_DWn2GoASeL7KD9EGVUlm75iSWEZxJobIEihF0Rw0a59RHh9GPueJF4KdhjF4PID_7-L87_Ojitj6D65v7uzt6Z2u6_Rhu5HHpKULFCizPZyfuCVw1p_OjdvY0rt0UPl82-P8AWu6EkQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB1VW1Rx4Rs1UCBIcAJr48Te2AeEgO2KVelqhUAqJ5P4g1aCpGy2Bf4av46xk2zZSvTWA8ckduIkb8YvmecZgCcmcc6VjBOk9pYwnHBJwYUkrJQ6MykSbONCsYl8NhMHB3K-Ab_7tTBeVtn7xOCoTa39P_JhmlOf6V1yPnSdLGI-nrw8_k58BSkfae3LabQQ2bO_fuDnW_NiOsZ3_TRNJ7sf3rwlXYUBornIloTnVItSu5wWxhUJc7R01EijhaVWOl-MuShSkyRWZKPc4fBLZ_JEWJNoUwqf9ADd_yZScpYOYHM-3Z9_Wv3h8dx8xHm3UifJxLBhPixIvIDeR-Ao4WuzYSgasMZ0z-s0zwVrwxw4uf4_P70bcK1j3vGr1lRuwoatbsHWfqctuA3vd3_WTf3NNnFRmVh7a1jEJB63WkTsFPZ7PVu36TMXeHHTou3x10q2-NQe-ovcgY-Xckd3YVDVld2G2AhrdckzKeSISWRVeAbsiYxTY1smI6D9m1e6S8fuq4J8VUEWkAnVokUhWlRAi-IRPFv1OW6TkVzY-rUH1KqlTyQedtSLL6rzS8q4DAkjzSwtLXPayJQXeZEVAq3WGGYi2OkBpTrv1qgzNEXweHUY_ZIPNhWVrU9CG84ywWUSQb4G47UBrR-pjg5DhnPJcmSu-Iye94A_u_i_b_jexWN9BFuIefVuOtu7D1fTYIWSUL4Dg-XixD6AK_p0edQsHnaGHMPny0b_HyeIjto |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes+and+cancer+-+Diagnostic+and+prognostic+biomarkers+and+therapeutic+vehicle&rft.jtitle=Oncogenesis+%28New+York%2C+NY%29&rft.au=Wang%2C+Xia&rft.au=Tian%2C+Lu&rft.au=Lu%2C+Jingyi&rft.au=Ng%2C+Irene+Oi-Lin&rft.date=2022-09-15&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2157-9024&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41389-022-00431-5&rft_id=info%3Apmid%2F36109501&rft.externalDocID=PMC9477829 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-9024&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-9024&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-9024&client=summon |